"Low Dose" Metformin Improves Hyperglycemia Better Than Acarbose in Type 2 Diabetics

OBJECTIVES: "High dose" metformin therapy (2,550 mg/day) is reported to improve glycemic control in type 2 diabetic patients with obesity (body mass index (BMI) ≥ 30). Some have reported that metformin therapy, even in low doses (500-750 mg/day), improves glycemic control in non-obese type...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Yajima, Ken, Shimada, Akira, Hirose, Hiroshi, Kasuga, Akira, Saruta, Takao
Formato: Artigo
Idioma:Inglês
Publicado: SBDR - Society for Biomedical Diabetes Research 2004
Assuntos:
Original Data
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1783540/
https://ncbi.nlm.nih.gov/pubmed/17491670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2004.1.89
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares